INVASION Season 3 Teaser Trailer Unleashes the Full Fury of the Alien War — GeekTyrant
As the 'ultimate apex aliens' spread their deadly tendrils across the globe, the series levels up in scale and urgency.
Invasion 'follows an alien invasion through different perspectives around the world. In Season 3, those perspectives collide for the first time, as all the main characters are brought together to work as a team on a critical mission to infiltrate the alien mothership.
'The ultimate apex aliens have finally emerged, rapidly spreading their deadly tendrils across the entire planet. It will take all heroes working together, using their experience and expertise, to save the human species. New relationships are formed, old relationships are challenged and even shattered, as an international cast of characters must become a team before it's too late.'
Returning cast members include Golshifteh Farahani, Shioli Kutsuna, Shamier Anderson, India Brown, Shane Zaza, and Enver Gjokaj, with Erika Alexander joining the mix.
Created by Simon Kinberg ( X-Men: Days of Future Past ) and David Weil ( Hunters ), the show continues to draw inspiration from War of the Worlds while carving its own identity as a globe-spanning, emotionally grounded alien invasion saga.
If Season 3 sticks the landing, Invasion might just become one of sci-fi TV's most ambitious slow-burn payoffs.
Season 3 kicks off August 22, 2025,
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gizmodo
27 minutes ago
- Gizmodo
Why Pooping on Planes Might Actually Be a Good Thing
Researchers have developed a new critical warning system for the spread of antimicrobial resistant (AMR) superbugs: poop and pee from airplane bathrooms. Scientists predict that by 2050, AMR superbugs, or pathogens that don't respond to antimicrobial medicines, might take more lives than cancer. As such, it's critical for countries to keep an eye on the global propagation of these dangerous pathogens, which can travel with people, in order to best prepare for future infections. In a study published in May in the journal Microbiology Spectrum, a team of international researchers suggests that aircraft toilet wastewater could warn authorities about the arrival of such superbugs. 'Long-haul flight aircraft wastewater may serve as a representative microbial footprint, often of mixed country origin, offering valuable insight into the movement of pathogens and antimicrobial resistance (AMR) on a global scale,' the team wrote in the study. 'Herein, we present a proof-of-concept for aircraft-based surveillance of AMR by investigating lavatory wastewater samples from 44 repatriation flights to Australia departing from nine countries.' The analysis revealed nine dangerous pathogens, including some superbugs that are resistant to more than one drug. The team investigated the superbugs' genetic signatures and antibiotic resistance gene (ARG) profiles, finding a gene that lends resistance to last-resort antibiotics on 17 flights. Interestingly, this dangerous gene was not present in Australia's urban wastewater at the time, indicating its arrival via international travel. All 44 flight samples had five out of the nine superbugs. 'Aircraft wastewater captures microbial signatures from passengers across different continents, offering a non-invasive, cost-effective way to monitor threats like AMR,' Warish Ahmed, a senior author of the study and researcher from CSIRO, said in a University of South Australia statement. Eighteen of the flights came from India, 14 from the United Kingdom, six from Germany, and one each from France, the United Arab Emirates, Turkey, South Africa, Japan, and Indonesia. According to Nicholas Ashbolt, a co-author of the study and a microbiologist at the University of South Australia, flights from Asia, especially from India, revealed greater concentrations of antibiotic-resistance genes than those from Europe and the United Kingdom. These distinctions could be due to differences in antibiotic use, water sanitation, population density, and public health policies. 'International travel is one of the major drivers of AMR spread,' said Yawen Liu, lead author of the study and a postdoctoral fellow at Xiamen University. 'By monitoring aircraft wastewater, we can potentially detect and track antibiotic resistance genes before they become established in local environments.' Tuberculosis, influenza, and SARS-CoV-2, for example, can also spread by air travel. While the researchers collected the wastewater samples from Covid-19 pandemic repatriation flights, potentially swaying passenger demographics, they argue that similar methods can also work for regular international travel. 'With AMR projected to cause more than 39 million deaths globally by 2050, the need for innovative surveillance tools is urgent,' Ashbolt concluded. 'Aircraft wastewater monitoring could complement existing public health systems, providing early warnings of emerging superbug threats.'
Medscape
27 minutes ago
- Medscape
Diagnosis of Renal Cell Carcinoma: 5 Things to Know
Renal cell carcinoma (RCC), the most common form of kidney cancer, accounts for approximately 90%-95% of all primary renal malignancies. When diagnosed at an early, localized stage, RCC carries a favorable prognosis with a 5-year relative survival rate of 93%. However, survival drops significantly with disease progression, falling to approximately 75% for regional disease and just 18% for metastatic disease, underscoring the importance of early diagnosis. Because RCC often remains asymptomatic in its early stages, it is frequently discovered incidentally or goes undetected until progression occurs. Routine CT screening for RCC is neither practical nor cost-effective, prompting interest in more efficient, targeted diagnostic strategies. Advances in imaging and the integration of artificial intelligence (AI) are helping clinicians detect RCC earlier and with greater accuracy. Here are five things to know about the diagnosis of RCC and the evolution of diagnostic technologies. 1. Imaging is the cornerstone of RCC diagnosis. Up to 60% of RCCs are discovered incidentally, most often during abdominal imaging — particularly CT scans — performed for unrelated indications. Patients with incidentally discovered RCC tend to have better outcomes than those diagnosed after symptom onset, as incidental detection is more likely to identify tumors at a surgically resectable and nonmetastatic stage. Cross-sectional imaging, particularly contrast-enhanced CT, remains the primary modality for evaluating suspected RCC and is used routinely for both diagnosis and post-treatment surveillance. CT provides high-resolution assessments of tumor morphology, enhancement patterns, size, location, and venous invasion — information that is critical for accurate staging and surgical planning. MRI is an important alternative when CT is contraindicated, such as in patients with renal insufficiency or iodine allergy, or when CT findings are inconclusive. MRI offers excellent soft-tissue contrast and is particularly useful for delineating tumor extension into the renal vein or inferior vena cava. Multiparametric MRI enhances evaluation by generating high-resolution images that help differentiate benign from malignant masses and reveal tumor-specific characteristics, such as vascularity or cellular density, that may aid in subtype classification. Ultrasonography is a useful first-line tool in the evaluation of renal masses, particularly for distinguishing cystic from solid renal lesions. While it lacks the sensitivity and spatial resolution of CT or MRI — especially for small or isoechoic tumors — it is noninvasive, cost-effective, and widely available, making it a practical choice for routine imaging. It is particularly effective in the initial characterization of simple renal cysts and monitoring Bosniak category I and II lesions. Advanced CT technologies are enhancing the characterization of renal lesions while reducing radiation exposure and contrast-agent requirements. In centers where available, dual-energy CT allows quantification of iodine content, which can help differentiate enhancing solid masses from cystic or nonenhancing lesions. It also enables virtual unenhanced imaging, potentially eliminating the need for noncontrast scans. Photon-counting CT improves spatial resolution and material decomposition, which may aid in detecting subtle renal lesions. Early clinical studies show it offers image quality and lesion conspicuity comparable to, or exceeding, conventional CT and MRI. PET/CT with tracers such as 18F-FDG, 124I-girentuximab, and PSMA-targeted agents (eg, 68Ga-PSMA) are under investigation for both diagnosis and treatment monitoring in RCC. These molecular imaging tools have shown promise for detecting primary tumors and metastatic disease. The phase 3 ZIRCON trial showed that 89Zr-girentuximab PET/CT achieved 85% sensitivity and 87% specificity for identifying clear-cell RCC. Bone scans are typically reserved for patients with bone pain or elevated alkaline phosphatase levels suggestive of skeletal metastases. PET/CT with 18F-FDG may aid in staging and treatment response assessment, particularly in aggressive or metabolically active RCC subtypes, although their utility varies depending on RCC subtype and metabolic activity. 2. AI is enhancing imaging interpretation. AI is becoming increasingly integrated into RCC diagnosis, particularly in the analysis of CT and MRI scans. AI algorithms can help radiologists identify and characterize renal masses with high accuracy, helping to distinguish benign from malignant lesions and potentially reducing unnecessary biopsies. Radiomics, a subfield of AI, extracts and analyzes high-dimensional imaging features not visible to the human eye. Radiomics-based models have been used to classify RCC subtypes, predict tumor behavior, and support prognostic and treatment decisions, especially in complex or ambiguous cases. AI can also automate nephrometry scoring systems, which quantify renal tumor complexity based on parameters such as size, location, and proximity to critical structures. These scores guide surgical decision-making, including the feasibility of partial nephrectomy. Automated systems may help reduce inter-reader variability and streamline preoperative planning. 3. Laboratory testing aids the initial evaluation. While imaging is essential, laboratory studies play a critical role in the initial evaluation and ongoing management of patients with RCC. In patients presenting with hematuria, flank pain, unexplained weight loss, or systemic findings, recommended laboratory tests typically include: Urinalysis, with urine cytology if a centrally located lesion suggests possible urothelial carcinoma Complete blood cell count with differential Serum electrolytes and renal function tests (eg, creatinine, blood urea nitrogen) Liver function tests (aspartate aminotransferase, alanine aminotransferase), which may be abnormal in the presence of paraneoplastic Stauffer syndrome Serum calcium to assess for hypercalcemia, a common paraneoplastic finding RCC is associated with several paraneoplastic syndromes, including: Hypercalcemia (due to ectopic parathyroid hormone-related protein production) Erythrocytosis (from ectopic erythropoietin secretion) Stauffer syndrome, a reversible nonmetastatic hepatic dysfunction Identifying these laboratory abnormalities can support a diagnosis of RCC, guide further testing, and influence management decisions, especially in advanced or atypical presentations. 4. Biopsy may be needed in select cases. Although RCC is often diagnosed based on imaging findings, biopsy remains an important tool in select cases, particularly when imaging findings are inconclusive, histologic confirmation is required prior to treatment, or active surveillance is being considered. The choice of biopsy technique depends on tumor size, tumor location, patient comorbidities, and the specific clinical context. Common approaches include: Percutaneous core needle biopsy: This is typically performed under CT or ultrasound guidance. It is the most frequently used method for renal biopsy, provides tissue for histopathologic and immunohistochemical analysis, and carries a low complication rate. Fine-needle aspiration (FNA): FNA may be used to obtain cytologic material. FNA is often used as an adjunct to core biopsy; it is less definitive when used alone. Laparoscopic or surgical biopsy: This may be necessary when percutaneous biopsy is not feasible, such as with deep or anatomically challenging tumors or when larger tissue samples are needed for molecular profiling. Liquid biopsy approaches — including analysis of circulating tumor DNA, circulating tumor cells, or other biomarkers — are currently investigational but may offer future utility in RCC diagnosis, prognosis, and treatment monitoring, particularly for identifying minimal residual disease or recurrence. Histologic analysis can confirm the diagnosis of RCC, distinguish between subtypes (eg, clear cell, papillary, chromophobe), and help determine the prognosis and treatment strategy. 5. Accurate staging and grading inform the diagnosis and prognosis. Staging and grading are essential components of the RCC diagnostic process. Together, they inform prognosis, guide treatment selection, and determine eligibility for surgical or systemic therapy. Staging follows the TNM system and assesses: Tumor size and local extent (T) Regional lymph node involvement (N) Presence of distant metastases (M) Grading evaluates the tumor's cellular features to estimate its aggressiveness. While the older Fuhrman grading system may still appear in some contexts, most institutions now use the ISUP/WHO grading system, which assesses nuclear characteristics in clear-cell and papillary RCC. Final stage and grade are based on the integration of imaging findings and histologic evaluation from biopsy or surgical specimens. These metrics are critical for risk stratification and treatment planning, including decisions regarding active surveillance, nephrectomy, or systemic therapy.
Forbes
28 minutes ago
- Forbes
How 'Cringe Culture' Is Hindering Professional Growth for Gen Z
This is a three-part series about how Gen Z culture is influencing career trajectories Part 1: The Cultural Origins of Cringe and Its Workplace Manifestations Ironic detachment and professional ambivalence are becoming the calling cards for a generation of young employees in the post-Covid era. Statistics reveal that Gen Z workers are at higher risk of being fired and one in six employers are reportedly hesitant to hire Gen Z. Many Gen Z professionals (born between 1997 and 2012) have entered the workforce conditioned to avoid any appearance of emotional vulnerability or earnest ambition. The unspoken rules are clear: Don't try too hard, don't care too much, and avoid 'being cringe.' What Is Cringe Culture? 'Cringe culture' emerged from informal social policing on social media, but it is also prevalent in real-life interactions. Behaviors that are tagged as awkward or overly eager are shared and mocked. 'Did you see what Sophia posted? God, it was so cringe!' Cringe culture is evident in YouTube 'fail' compilations, TikTok duets that provide commentary on the targeted post, and Reddit forums that chronicle missteps and mishaps. Managing one's personal reputation used to be a preoccupation mainly for celebrities and PR firms, but Gen Z's habitation of digital spaces allows their every move (or post) to be scrutinized and judged by their peers. Screen shots of photos or text messages can be circulated faster than the speed of light. The unrelenting anxiety of doing something that could be perceived as 'cringe' leads some Gen Z adults to a chronic state of functional freeze. Sincere effort and ambition have become socially risky behaviors. In Gen Z's calculus, the cost of potential censure is too high. The Psychological Impact This hyper-consciousness breeds extreme social rejection sensitivity and a preference for 'play it safe' and 'stay in your lane' behaviors. The fear of humiliation is matched by the fear of being seen as a 'try hard.' Ironic detachment has become a default setting for Gen Z workers focused on self-preservation. 'If you don't know I tried, I can't be judged if I ultimately fail.' Educators and developmental experts know that fear of failure can inhibit learning and growth in the classroom. The developmental cost of 'cringe culture' in the workplace is stalled careers and stunted professional growth. Workplaces reward visibility, risk-taking, and speaking up. But Gen Z has been conditioned to avoid the appearance of effort and potential failure in front of others. Professors have noted that Gen Z is reluctant to raise their hand to speak in class. This fear of being wrong, being ridiculed, or being labeled as 'cringe' follows young adults into their professional spheres, too. How Cringe Culture Manifests at Work Leaders may observe Gen Z employees and interpret reticence as disengagement, hesitation as lack of initiative, or emotional detachment as immaturity. The Gen Z stare has been documented and widely interpreted as rude and disrespectful. But these common behaviors reveal an internal conflict and lack of psychological safety. The fear of being 'cringe' can lead to behaviors that stall professional development. The discourse about Gen Z in the workplace often centers on their lack of preparedness or unsteady work ethic. But understanding the psychology of 'cringe culture' can illuminate and reframe the conversation. Most organizations will depend on this generation of workers and need for them to be successful. Coming in Parts 2 and 3: The organizational impact of cringe culture and what leaders can do to create developmental paths for Gen Z
